Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
naratriptan 5-hydroxytryptamine receptor 1a small molecule NA drugbank , DGIDB Aura[MeSHID:D004827]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.48 approved,investigational agonist
naratriptan 5-ht 1b receptor NA Successful target TTD , DGIDB Aura[MeSHID:D004827]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
2.74 approved agonist
naratriptan 5-hydroxytryptamine receptor 1b small molecule NA drugbank , DGIDB Aura[MeSHID:D004827]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
2.74 approved,investigational agonist
naratriptan 5-ht 1b receptor NA Successful target TTD , DGIDB Aura[MeSHID:D004827]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
2.74 approved unknown
naratriptan 5-hydroxytryptamine receptor 1d small molecule NA drugbank , DGIDB Aura[MeSHID:D004827]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
3.18 approved,investigational agonist
naratriptan 5-hydroxytryptamine receptor 1f small molecule NA drugbank , DGIDB Aura[MeSHID:D004827]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
4.39 approved,investigational agonist
click here to return to the previous page